Press Releases

Date	Title	Company
24-Jan-2022	WuXi STA Launches its First Parenteral Formulation Manufacturing Line	WuXi STA
24-Jan-2022	Explora BioLabs Launches Preclinical Vivarium Model in Seattle	Newswire
24-Jan-2022	Atrial Fibrilillation Study by NativeCardio and the Texas Heart Institute Show Ultra-Low Cardioversion is Possible	Newswire
24-Jan-2022	NICE EXPANDS GUIDANCE FOR LOKELMA®▼(sodium zirconium cyclosilicate) IN ADULT PATIENTS WITH PERSISTENT HYPERKALAEMIA	AstraZeneca
24-Jan-2022	Cellvera Receives $20M Purchase Order for COVID-19 Oral Antiviral Avigan®	Newswire
24-Jan-2022	Prime Global acquires HCD Economics, creating an innovative evidence-generating, HEOR, value & communications group	Prime Global
24-Jan-2022	Original-Research: Defence Therapeutics Inc. (von GBC AG)	Defence Therapeutics Inc.
24-Jan-2022	CD Genomics: The Biomedical Bioinformatics Platform Unveils Biomarker and Target Discovery Data Analysis Service	CD Genomics
24-Jan-2022	Successful completion of FY/2021 with +34% growth in Q4 leading to significant sales increase in 2021 (+30%); further sales growth and EBITDA improvement planned for FY/2022	aap Implantate AG
24-Jan-2022	Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering Ready to Use Diclofenac Stick Packs	RELIEF THERAPEUTICS Holding AG
24-Jan-2022	Supervisory Board of Epigenomics AG Retains Greg Hamilton as Chief Executive Officer Through Development of Epi proColon 'Next-Gen' Colorectal Cancer Screening Test	Epigenomics AG
22-Jan-2022	Creative Enzymes Introduces Instant Granules to Shorten the Experimental Process	Creative Enzymes
21-Jan-2022	AiPharma Announces Corporate Rebrand, Changing Its Name to Cellvera	Newswire
21-Jan-2022	Navigating the challenges and legal landscapes of parallel trade	SMi Group
21-Jan-2022	First Platform for Massively Multiplexed Single-Cell In Situ Spatial Genomics Now Broadly Available to U.S. Market	Vizgen
21-Jan-2022	PolyPhotonix Secures Multimillion Pound US Investment and Strategic Alliance for Sight Saving Mask	PolyPhotonix Limited
21-Jan-2022	Abzena appoints Jim Kennamer as SVP and Site Head of North Carolina	Abzena
21-Jan-2022	CD Formulation Provides Tailor-made Solutions for Thickener Excipients for Drug Development	CD Formulation
21-Jan-2022	CD Formulation: Customized Preparation of Active Pharmaceutical Ingredient Excipients to Accelerate Drug Formulation Projects	CD Formulation
21-Jan-2022	Quantum Dots & Upconverting Nanoparticles Provided by Alfa Chemistry Can Improve Medical Technology and Energy Research	Alfa Chemistry